Literature DB >> 17105494

Characterization of several amino acid transports and glutamine metabolism in MOLT4 human T4 leukemia cells.

H Ochiai1, K Higa, N Hishiyama, S Hisamatsu, H Fujise.   

Abstract

The transport system responsible for glutamine, alanine and glutamate in MOLT4 human T4 leukemia cell line were characterized. Kinetic studies of sodium-dependent glutamine and alanine transport exhibited a single saturable high-affinity carrier with a Michaelis constant of 152 +/- 26 microm and 203 +/- 36 microm and a maximal transport velocity of 960 +/- 165 and 1096 +/- 208 nmol/10(9)cells/min, respectively. Glutamate uptake was less than one-tenth of glutamine and alanine, and linearly increased with glutamate concentration which was mediated by diffusion. 4-acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic acid (SITS), known as anion channel blockers, inhibited the sodium-dependent glutamine and alanine transport by 40% at 10 microm. Cellular contents of these amino acids in MOLT4 cells revealed glutamate to be the highest among them despite low glutamate influx. A glutamine metabolism study using whole cells indicated this high conversion rate from glutamine to glutamate, but no conversion to another amino acid. Based on these results, the high glutamate concentration in MOLT4 was speculated to be synthesized from transported glutamine by active glutaminase.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17105494     DOI: 10.1111/j.1365-2257.2006.00842.x

Source DB:  PubMed          Journal:  Clin Lab Haematol        ISSN: 0141-9854


  1 in total

1.  Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia.

Authors:  Lise Willems; Nathalie Jacque; Arnaud Jacquel; Nathalie Neveux; Thiago Trovati Maciel; Mireille Lambert; Alain Schmitt; Laury Poulain; Alexa S Green; Madalina Uzunov; Olivier Kosmider; Isabelle Radford-Weiss; Ivan Cruz Moura; Patrick Auberger; Norbert Ifrah; Valérie Bardet; Nicolas Chapuis; Catherine Lacombe; Patrick Mayeux; Jérôme Tamburini; Didier Bouscary
Journal:  Blood       Date:  2013-09-06       Impact factor: 22.113

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.